financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of The Chemours Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of The Chemours Company
May 26, 2025 3:45 AM

02:25 AM EDT, 05/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target at $9, using a forward P/E of 5x our 2026 EPS view of $1.86 (cut by $0.17), below the three-year average of 6.5x on near-term fundamental concerns, lingering litigation issues, and heightened macroeconomic uncertainty. We also cut 2025 EPS to $1.49 from $1.58. Q1 sales were flat Y/Y, as declines in Advanced Performance Materials (APM) and a 44% decline in the Freon refrigerant within Thermal & Specialized Solutions (TSS) were fully offset by gains in Titanium Technologies (TT) and a 40% jump in the Opteon refrigerant within TSS. Adj. EBIT margin fell 320 bps Y/Y on lower pricing, mainly due to Freon weakness and regional pricing dynamics in TT, along with unfavorable FX translation and lower volumes in APM. Sales/volume/price by segment: TSS (34% of Q1 sales) +3%/+10%/-6%, TT (44%) +1%/+6%/-4%, and APM (22%) -3%/-1%/flat. We keep our Strong Sell view, driven by lingering litigation issues and deteriorating fundamentals/debt coverage ratios, supported by CC's 65% dividend cut in Q1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lowers Opinion On Shares Of Stellantis N.v. To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Stellantis N.v. To Hold From Buy
Mar 22, 2024
08:30 AM EDT, 03/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target by $2 to $30, based on a '25 P/E of 4.7x, a justified premium to its historical average forward P/E of 4.3x. Our estimates are...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Apple Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Apple Inc.
Mar 22, 2024
08:20 AM EDT, 03/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: The U.S. is suing AAPL, accusing it of monopolizing the smartphone market by citing that AAPL makes it difficult for competitors to integrate with the iPhone, thus raising prices and...
Research Alert: CFRA Lowers Opinion On Shares Of Stellantis N.v. To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Stellantis N.v. To Hold From Buy
Mar 22, 2024
08:25 AM EDT, 03/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target by $2 to $30, based on a '25 P/E of 4.7x, a justified premium to its historical average forward P/E of 4.3x. Our estimates are...
Research Alert: CFRA Raises Opinion On Shares Of Lululemon Athletica To Strong Buy From Buy
Research Alert: CFRA Raises Opinion On Shares Of Lululemon Athletica To Strong Buy From Buy
Mar 22, 2024
08:15 AM EDT, 03/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month price target of $550, based on 37.9x our FY 25 (Jan.) EPS estimate and below the company's 5-year average forward P/E multiple of 42.7x. We maintain...
Copyright 2023-2025 - www.financetom.com All Rights Reserved